Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix

Annals of Oncology

Volumn 7, Issue 5, 1996, Pages 511-516

  Pras, E ^a   Willemse, P H B ^a   Boonstra, H ^a   Hollema, H ^a   Heesters, M A A M ^a   Szabo B G ^a   De Bruijn, H W A ^a   Aalders, J G ^a   De Vries, E G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

5 Fluorouracil; Carboplatin; Cervical cancer; Chemotherapy; Radiotherapy

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL; UTERINE CERVIX CARCINOMA;

EID: 0030056582     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010641     Document Type: Article

References (38)

1. Stehman FB, Thomas GM. Prognostic factors in locally advanced carcinoma of the cervix treated with radiation therapy. Semin Oncol 1994; 21: 25-9.
2. Pettersen F. 21th Annual report of the results of treatment in gynaecological cancer. Int J Obstet Gynecol 1991; 36 (Suppl): 27-130.
3. Van Nagell JR, Rayburn W, Donaldson ES et al. Therapeutic implications of patterns of recurrence in cancer of the uterine cervix. Cancer 1979; 44: 2354-61.
4. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976; 126: 785-98.
5. Russel AH. Contemporary radiation treatment planning for patients with cancer of the uterine cervix. Semin Oncol 1994; 21: 30-41.
6. Vermorken JB. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynaecol Cancer 1993; 3: 129-42.
7. Thigpen JT, Blessing JA, DiSaia PJ et al. A randomized comparison of a rapid versus prolonged (24-hours) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynaecologic Oncology Group study. Gynecol Oncol 1989; 32: 198-202.
8. Bonomi P, Blessing JA, Stehman FB et al. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: A Gynaecologic Oncology Group Study. J Clin Oncol 1985; 3: 1079-85.
9. Arseneau J, Blessing JA, Stehman FB et al. A phase II study of carboplatin in advanced squamous cell carcinoma of cervix (a Gynecologic Oncology Group study). Invest New Drugs 1986; 4: 187-91.
10. Noda K, Kato T, Ikeda M et al. Phase II study of carboplatin in cervical carcinoma. Gan to Kagaku Ryoho 1988; 15: 3067-72.
11. McGuire WP III, Blessing JA, Arseneau J et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group Study. J Clin Oncol 1989; 7: 1462-8.
12. Weiss GR, Green S, Hannigan EV et al. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: A SWOG study. Gynecol Oncol 1990; 39: 332-6.
13. Lira-Puerto V, Silva A, Morris M et al. Phase II trial of carboplatin or iproplatin in cervical cancer. Cancer Chemother Pharmacol 1991; 28: 391-6.
14. Rustin GJ, Newlands ES. Phase I-II study of carboplatin, vincristine, methotrexate and bleomycin (COMB) in carcinoma of the cervix. Br J Cancer 1988; 58: 818-9.
15. Junor E, Davies J, Habeshaw T et al. Carboplatin-based combination chemotherapy for advanced carcinoma of the cervix. Cancer Chemother Pharmacol 1991; 27: 484-6.
16. Kuehnle H, Meerpohl H-G, Eiermann W et al. Neoadjuvant therapy for cervical cancer. Semin Oncol 1992; 19: 94-8.
17. Murad AM, Triginelli SA, Ribalta JC. Phase II trial of bleomycin, ifosfamide and carboplatin in metastatic cervical cancer. J Clin Oncol 1994; 12: 55-9.
18. Alvarez MV, Cobreros EA. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br J Cancer 1978; 37: 68-72.
19. Douple EB, Richmond RC. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II). Int J Radiat Oncol Biol Phys 1979; 5: 1369-72.
20. Goolsby CD, Daly JW, Skinner OD et al. Combination of 5-fluorouracil and radiation as primary therapy of carcinoma of the cervix. Obstet Gynecol 1986; 32: 674-6.
21. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
22. Wertheim MS, Hakes TB, Daghestani AN et al. A pilot study of adjuvant therapy in patients with cervical cancer at high risk of recurrence after radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 1985; 3: 912-6.
23. Lai CH, Lin TS, Soong YK et al. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol 1989; 35: 193-8.
24. Potish RA, Twiggs LB. On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. Int J Radiat Oncol Biol Phys 1993; 27: 975-9.
25. Vokes EE, Kies M, Haraf DJ et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 1995; 13: 876-83.
26. Furuse K, Kubota K, Kawahara M et al. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage in non-small cell lung cancer. J Clin Oncol 1995; 13: 869-75.
27. Thomas GM, Dembo A, Fyles A et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990; 38: 446-51.
28. Roberts WS, Kavanagh JJ, Greenberg H et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced carcinoma of the female genital tract. Gynecol Oncol 1989; 34: 183-6.
29. Kuske RR, Perez CA, Grigsby PW et al. Phase I-II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Am J Clin Oncol 1989; 12: 467-73.
30. Heaton D, Yordan E, Reddy S et al. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil and split course hyperfractionated radiation therapy. Gynecol Oncol 1990; 38: 323-7.
31. Husseinzadeh N, Shrake P, DeEulis T et al. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to paraaortic nodes: A phase II pilot study. Gynecol Oncol 1994; 52: 326-30.
32. Park TK, Lee SK, Kim SN et al. Combined chemotherapy and radiation for bulky stages I-II cervical cancer: Comparison of concurrent and sequential regimens. Gynecol Oncol 1993; 50: 196-201.
33. Maruyama Y, Bowen MG, Van Nagell JR et al. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer. Int J Radiat Oncol Biol Phys 1994; 29: 529-34.
34. Resbeut M, Cowen D, Viens P et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol 1994; 54: 68-75.
35. Chang HC, Lai CH, Chen MS et al. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine and bleomycin in bulky advanced cervical carcinoma: A pilot study. Gynecol Oncol 1992; 44: 182-8.
36. Choo YC, Choy TK, Wang LG et al. Potentiation of radiotherapy by cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 1989; 34: 395-401.
37. Pearcey RG, Stuart GCE, MacLean GD et al. Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol 1995; 58: 34-41.
38. Arai T, Nakano T, Oka K. Local control prediction by histologic grading of radiation effects with drill biopsy specimens for uterine cervical cancer. Int J Radiat Oncol Biol Phys 1993; 27: 811-6.